PACT Fulfillment Category

FDA Data Element Number. None.

CDER Data Element Number. C-DRG-00920

Version Number. 001

Data Element Name. PACT Fulfillment Category

Description. This standard provides for all PACT study fulfillment categories. PACT studies are post-marketing studies for the Office of Generic Drug Products that are imposed upon a pharmaceutical firm as a condition for drug approval. Defining the various fulfillment categories for each study will permit CDER management to determine trend analysis.

Source. Office of Generic Drug Products

Relationship. PACT Commitment Category

FDA Specifications. None.

CDER Specifications. PACT Category shall consist of an alphabetic term which has a maximum length restricted to 100 characters, with the comma and hyphen being the only punctuation permissible. Codes representing these PACT Fulfillment Categories shall consist of two digits separated by a decimal.

FDA Approved Date. None.

CDER Approved Date. January 21, 2000

FDA Revised Date.

CDER Revised Date.

Data Values.

Study Not Begun, Will Begin in Future Literal 1.1
Study Not Begun, Company Did Not Agree to Conduct Study Literal 1.2
Study in Progress, Underway Literal 2.1
Report of Study Submitted, Deemed Adequate by FDA Literal 3.1
Report of Study Submitted, Deemed Inadequate by FDA Literal 3.2
Report of Study Submitted, No Adequacy Determination by FDA Literal 3.3


Page Last Updated: 12/10/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English